JMP Securities Upgrades AN2 Therapeutics (ANTX) to Market Outperform
Tweet Send to a Friend
(Updated - April 2, 2024 3:37 AM EDT)
JMP Securities analyst Roy Buchanan upgraded AN2 Therapeutics (NASDAQ: ANTX) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
JMP Securities analyst Roy Buchanan upgraded AN2 Therapeutics (NASDAQ: ANTX) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
